Skip to content

Clinical Eficacy and Safety of Warm Acupuncture in the treatment of Type 2 Diabetic Kidney Disease: A protocol of a randomized controlled trial

Clinical Eficacy and Safety of Warm Acupuncture in the treatment of Type 2 Diabetic Kidney Disease: A protocol of a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000067
Enrollment
Unknown
Registered
2024-05-19
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetic Kidney Disease

Interventions

test group:Basic treatment and Warm acupuncture treatment
control group:Basic treatment

Sponsors

Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of type 2 DKD; (2) Age =18 years old, and =70 years old, regardless of gender; (3) With the 24-hour urinary protein quantification was 0.5-3.5 g; (4) With serum creatinine < 265µmol/L (3mg/dl); (5) Patients voluntarily participated in the trial and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Nephropathy due to hypertension or other diseases; (2) Complicated with severe complications and other serious organ dysfunction; (3) Complicated with severe heart disease (NYHA class 3 or above, severe arrhythmia), abnormal liver function (alanine aminotransferase, aspartate aminotransferase = 1.5 times the upper limit of normal value), hematopoietic system diseases (moderate to severe anemia); (4) Complicated with severe infection, diabetic ketoacidosis, hyperkalemia; (5) Complicated with severe mental illness; (6) Pregnant or lactating women; (7) Patients with a history of allergy to one of the drugs used in the study; (8) Subjects participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
24-hour urinary protein quantification;

Secondary

MeasureTime frame
Serum creatinine;The TCM Syndrome score;

Countries

China

Contacts

Public ContactHongBo Chen

Zhejiang Chinese Medical University

chenhb521@126.com19932603738

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026